185 related articles for article (PubMed ID: 109512)
1. Complement lysis of resealed red cell membrane ghosts pretreated with glutaraldehyde.
Giavedoni EB; Chow YM; Dalmasso AP
J Immunol; 1979 May; 122(5):1643-8. PubMed ID: 109512
[No Abstract] [Full Text] [Related]
2. Complement-induced modifications in membrane fluidity: studies with resealed and glutaraldehyde-treated erythrocyte membrane ghosts.
Giavedoni EB; Mason RP; Dalmasso AP
J Immunol; 1978 Jun; 120(6):2003-7. PubMed ID: 207778
[No Abstract] [Full Text] [Related]
3. Determination of the number of lytic sites in biconcave and spheroid erythrocyte ghosts after complement lysis.
Bauer J; Podack ER; Valet G
J Immunol; 1979 May; 122(5):2032-6. PubMed ID: 448115
[No Abstract] [Full Text] [Related]
4. The functional size of the primary complement lesion in resealed erythrocyte membrane ghosts.
Giavedoni EB; Chow YM; Dalmasso AP
J Immunol; 1979 Jan; 122(1):240-5. PubMed ID: 570203
[No Abstract] [Full Text] [Related]
5. Glutaraldehyde-treated xenocells: a specific adsorbent for complement factors.
Schmer G; Newman ML; Rastelli L; Dennis MB
Trans Am Soc Artif Intern Organs; 1981; 27():445-8. PubMed ID: 6800100
[No Abstract] [Full Text] [Related]
6. Interactions of complement with the red-cell membrane.
Rosse WF
Semin Hematol; 1979 Apr; 16(2):128-39. PubMed ID: 384519
[TBL] [Abstract][Full Text] [Related]
7. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.
Nemerow GR; Yamamoto KI; Lint TF
J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249
[No Abstract] [Full Text] [Related]
8. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
Hänsch GM; Schönermark S; Roelcke D
J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
[TBL] [Abstract][Full Text] [Related]
9. The structural events associated with the attachment of complement components to cell membranes in reactive lysis.
Dourmashkin RR
Immunology; 1978 Aug; 35(2):205-12. PubMed ID: 750370
[TBL] [Abstract][Full Text] [Related]
10. Activation of human complement by glutaraldehyde-treated red cells.
Hughes-Jones NC; Gardner B; Rowlands J
Nature; 1977 Dec; 270(5638):613-4. PubMed ID: 413056
[No Abstract] [Full Text] [Related]
11. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
12. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
Rosenfeld SI; Jenkins DE; Leddy JP
J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
[TBL] [Abstract][Full Text] [Related]
13. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
[TBL] [Abstract][Full Text] [Related]
14. Cell volume and osmotic properties of erythrocytes after complement lysis measured by flow cytometry.
Bauer J; Valet G
J Immunol; 1983 Feb; 130(2):839-44. PubMed ID: 6848597
[TBL] [Abstract][Full Text] [Related]
15. Analysis of solute diffusion across the C5b-9 membrane lesion of complement: evidence that individual C5b-9 complexes do not function as discrete, uniform pores.
Sims PJ; Lauf PK
J Immunol; 1980 Dec; 125(6):2617-25. PubMed ID: 7430641
[TBL] [Abstract][Full Text] [Related]
16. Restriction in the lytic efficiency of complement of different erythrocyte targets: a re-examination of the activities of horse C8 and C9.
Yarnall DP; Boyle MD
Mol Immunol; 1986 Aug; 23(8):823-9. PubMed ID: 3796626
[TBL] [Abstract][Full Text] [Related]
17. Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.
Packman CH; Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1980 Jun; 124(6):2818-23. PubMed ID: 7189536
[No Abstract] [Full Text] [Related]
18. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
Parker CJ; Wiedmer T; Sims PJ; Rosse WF
J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
[TBL] [Abstract][Full Text] [Related]
19. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
Schönermark S; Filsinger S; Berger B; Hänsch GM
Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
[TBL] [Abstract][Full Text] [Related]
20. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
